当前位置:

网站首页>文章详情

小而密低密度脂蛋白与心血管疾病关系

【PDF在线阅读】 【下载PDF】
  • Author:

  • Author Unit:

  • 关键词:

  • Keywords:

  • 中图分类号:

摘要:

Abstract:

基金项目:

参考文献:

[1] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J]. 中
国循环杂志,2019,34(3):209-20.
[2] Grundy SM,Stone NJ,Bailey AL,et al. 2018 AHA/ACC/AACVPR/AAPA/
ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the
Management of Blood Cholesterol: A Report of the American College of
Cardiology/American Heart Association Task Force on Clinical Practice
Guide-lines[J].Circulation,2019,139(25):e1082-e143.
[3] Hirayama S,Miida T. Small dense LDL:An emerging risk factor for
cardiovascular disease[J]. Clinica Chimica Acta,2012,414(1):215-24.
[4] Afanasieva OI,Utkina EA,Artemieva NV,et al. Elevated Lipoprotein(a)
Cncentration and Presence of Subfractions of Small Dense Low
Density Lipoproteins as Independent Factors of Risk of Ischemic
Heart Disease[J]. Kardiologiia,2016,56(6):5-11.
[5] Tsujita K,Yamanaga K,Komura N,et al. Lipid profile associated with
coronary plaque regression in patients with acute coronary syndrome:
Subanalysis of PRECISE-IVUS trial[J]. Atherosclerosis,2016,251
(Complete):367-72.
[6] Krauss RM,Burke DJ. Identification of multiple subclasses of plasma low
density lipoproteins in normal humans[J]. J Lipid Res,1982,23(1): 97-104.
[7] Austin MA,Breslow JL,Hennekens CH,et al. Low-density lipoprotein
subclass patterns and risk of myocardial infarction[J]. Jama,1988,260

(13):1917-21.

[8] Sninsky JJ,Rowland CM,Baca AM,et al. Classification of LDL
phenotypes by 4 methods of determining lipoprotein particle size[J]. J
Investig Med, 2013,61(6):942-9.
[9] Albers JJ,Kennedy H,Marcovina SM. Evaluation of a new homogenous
method for detection of small dense LDL cho-lesterol:comparison
with the LDL cholesterol profile obtained by density gradient
ultracentrifugation[J]. Clin Chim Acta,2011,412(7-8):556-61.
[10] Berneis KK,Krauss RM. Metabolic origins and clinical significance of
LDL heterogeneity[J]. J Lipid Res,2002,43(9):1363-79.
[11] Krauss RM,Wojnooski K,Orr J,et al. Changes in lipoprotein subfraction
concentration and composition in healthy individuals treated with the
CETP inhibitor anacetrapib[J]. J Lipid Res,2012,53(3):540-7.
[12] Ivanova EA,Myasoedova VA,Melnichenko AA,et al. Small Dense
Low-Density Lipoprotein as Biomarker for Atherosclerotic
Diseases.[J]. Oxidative Medicine and Cellular Longevity,2017,(2017-
5-7),2017(25):1-10.
[13] Soran H,Durrington PN. Susceptibility of LDL and its subfractions to
glycation[J]. Curr Opin Lipidol,2011,22(4):254-61.
[14] Younis NN,Soran H,Pemberton P,et al. Small dense LDL is more
susceptible to glycation than more buoyant LDL in Type 2 diabetes[J].
Clin Sci,2013,124(5):343-9.
[15] Krauss RM. Lipoprotein subfractions and cardiovascular disease
risk[J]. Curr Opin Lipidol,2010,21(4):305-11.
[16] Liansheng W,Xing Z,Yuqi F,et al.The detection of serum sdLDL-C in
the CAD patients and clinical application[J]. Heart,2011,97(Suppl 3):
A244-A.
[17] Goel PK,Ashfaq F,Khanna R,et al. The Association Between Small
Dense Low Density Lipoprotein and Coronary Artery Disease in North
Indian Patients[J]. Indian J Clin Biochem,2017,32(2):186-92.
[18] Satoh N,Wada H,Ono K,et al. Small dense LDL-cholesterol
relative to LDL-cholesterol is a strong independent determinant
o f h y p o a d i p o n e c t i n e m i a i n m e t a b o l i c s y n d r o m e [ J ] . C i r c
J,2008,72(6):932-9.
[19] Hoogeveen RC,Gaubatz JW,Sun W,et al. Small dense low-density
lipoprotein-cholesterol concentrations predict risk for coronary heart
disease:the Atherosclerosis Risk In Communities (ARIC) study[J].
Arterioscler Thromb Vasc Biol,2014,34(5):1069-77.
[20] Ivanova EA,Myasoedova VA,Melnichenko AA,et al. Small dense
low density lipoprotein particles are associated with poor outcome
after angioplasty in peripheral artery disease[J]. PloS one,2014,9(9):
e108813.
[21] Shen H,Xu Y,Lu J,et al. Small dense low-density lipoprotein
cholesterol was associated with future cardiovascular events in
chronic kidney disease patients[J].BMC nephrology,2016,17(1):143.
[22] Sakai K,Koba S,Nakamura Y,et al. Small dense low-density
lipoprotein cholesterol is a promising biomarker for secondary
prevention in older men with stable coronary artery disease[J]. Geriatr
Gerontol Int,2018,18(6):965-72.
[23] 安宁,邹德玲. 小而密低密度脂蛋白胆固醇及其与高密度脂蛋白
胆固醇比值与急性冠状动脉综合征的相关性研究[J]. 中国医师
进修杂志,2018,41(12):1080-5.
[24] 栾学冰,翁志远,马亮,等. 小而密低密度脂蛋白对PCI术后支架内
再狭窄的影响[J]. 心血管康复医学杂志,2018,27(5):516-9.
[25] 范雪松,王恩世,袁慧,等. 小而密低密度脂蛋白胆固醇及其与低
密度脂蛋白胆固醇之比与颈动脉粥样硬化斑块的关系[J].中华
检验医学杂志,2018,41(3):219-22.
[26] Fukushima Y,Hirayama S,Ueno T,et al. Small dense LDL cholesterol
is a robust therapeutic marker of statin treatment in patients with
acute coronary syndrome and metabolic syndrome[J]. Clin Chim
Acta,2011,412(15-16):1423-7.
[27] Kubo M,Miyoshi T,Kimura T,et al. Add-on ezetimibe reduces small
dense low-density lipoprotein cholesterol levels without affecting
absorption of eicosapentaenoic acid in patients with coronary artery
disease: a pilot study[J]. Am J Cardiovasc Drugs,2014,14(5):387-92.

  • 2008

  • 1

通讯地址:北京市东城区东四十条南门仓5号
电话: 237499284 邮编:100700
网址:www.ebcvm..org Email: ebcvm_cj@126.com

copyright © 《中国循证心血管医学杂志》编辑部
当您在使用本网站投稿遇到困难时,
请直接将稿件投送到编辑部邮箱ebcvm_cj@126.com